Despite challenges like regulatory compliance and device cost, ongoing technological advancements and expanding applications, particularly in dental and remote healthcare, are expected to sustain ...
Learn more about whether Charles River Laboratories International, Inc. or West Pharmaceutical Services, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' ...
Opinion
Zacks Investment Research on MSNOpinion
3 medical instrument stocks to counter industry woes using GenAI
Over the past year, the application of generative AI (genAI) in the Medical Instruments industry has moved from experimental to operational, transforming diagnostics, patient monitoring and ...
Here is the full list of the health and wellness Startup Battlefield 200 selectees, along with a note on what made us select ...
My daughter loves to camp and go off road. She has become enamored by the old Toyota Land Cruisers from the 1990s.” ...
The move suggests that shrinking margins, leadership turnover, and a shifting product mix are quietly reshaping the Lantheus investment case.
Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...
Initiate offers market access and HEOR consultancy services for clients across the pharmaceutical, medical device, and diagnostic sectors.
The approval is one of many advances the company has made this year toward expanding access to fertility treatments globally.
Clinical practice guidelines were developed to inform health providers of best practices for the management of sacroiliac joint complex pain.
Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.
As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results